Waters Corporation

Equities

WAT

US9418481035

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX Other stock markets 01:00:16 2024-04-23 pm EDT			5-day change	1st Jan Change
314 ^USD	+4.94%		+0.39%	-4.34%

Apr. 22	Bernstein Adjusts Price Target on Waters to $304 From $307	MT
Apr. 22	Baird Adjusts Price Target on Waters to $319 From $315	MT

Waters Corporation : Q4 2016 Financial Results Webcast Invitation

January 13, 2017 at 05:46 pm EST

Waters Corporation (NYSE:WAT) will webcast its Q4 2016 financial results conference call live on Tuesday, January 24^th at 8:00 a.m. eastern time. To listen to the conference call connect to Waters’ website, www.waters.com choose “Investors” and click on the Live Webcast. A replay of the webcast will be available until January 31^st at midnight eastern time.

About Waters Corporation

Waters Corporation (NYSE: WAT) develops and manufactures advanced analytical and material science technologies for laboratory dependent organizations. For more than 50 years, the company has pioneered a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis systems.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170113005763/en/

Latest news about Waters Corporation

Bernstein Adjusts Price Target on Waters to $304 From $307	Apr. 22	MT
Baird Adjusts Price Target on Waters to $319 From $315	Apr. 22	MT
Waters Corporation Accelerates the Development of Gene-Based Therapeutics with New GTxResolve Premier SEC Columns	Apr. 22	CI
Leerink Partners Adjusts Waters' Price Target to $338 From $335	Apr. 12	MT
Transcript : Waters Corporation Presents at TD Cowen 44th Annual Health Care Conference 2024, Mar-04-2024 11:10 AM	Mar. 04
Barclays Adjusts Waters Price Target to $300 From $275, Maintains Underweight Rating	Feb. 12	MT
UBS Adjusts Price Target on Waters to $345 From $285, Maintains Neutral Rating	Feb. 07	MT
Transcript : Waters Corporation, Q4 2023 Earnings Call, Feb 06, 2024	Feb. 06
Waters' Q4 Adjusted Earnings, Net Sales Decline	Feb. 06	MT
Earnings Flash (WAT) WATERS CORPORATION Posts Q4 Revenue $819.5M	Feb. 06	MT
Earnings Flash (WAT) WATERS CORPORATION Reports Q4 EPS $3.62	Feb. 06	MT
Waters Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 06	CI
Waters Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 06	CI
Waters Corporation Provides Earnings Guidance for the First Quarter and Full-Year 2024	Feb. 06	CI
BofA Securities Raises Price Target on Waters to $328 From $300, Maintains Neutral Rating	Jan. 29	MT
Barclays Adjusts Price Target on Waters to $275 From $230, Keeps Underweight Rating	Jan. 25	MT
Waters Corporation's Equity Buyback announced on January 23, 2019, has expired.	Jan. 20	CI
Transcript : Waters Corporation Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 04:30 PM	Jan. 08
Slow start for Wall Street	Jan. 03
Analyst recommendations: Blackstone, Citigroup, Icon, Amazon, Broadcom...	Jan. 03
BofA Securities Adjusts Price Target on Waters to $300 From $265, Maintains Neutral Rating	Dec. 12	MT
Powell is getting ready to crush investors 'hopes	Dec. 11
Citigroup Adjusts Price Target on Waters to $300 From $265, Keeps Neutral Rating	Dec. 11	MT
ANALYST RECOMMENDATIONS : Adobe, AMD, Apple, Costco, HP, Snap...	Dec. 11
Transcript : Waters Corporation Presents at The 6th Annual Evercore ISI HealthCONx Conference, Nov-30-2023 08:20 AM	Nov. 30

Chart Waters Corporation

Duration

Period

More charts

Company Profile

Waters Corporation specializes in the conception, the manufacturing and the marketing of analytical instruments. Net sales break down by activity as follows: - sale of instruments and analytical systems (63.6%): chromatographic analysis instruments (59.5% of net sales; instruments high performance liquid chromatography and mass spectrometry), chemistry consumables (28.9%; including columns chemical separation) and thermal analysis, rheometry and calorimetry instruments (11.6%) ; - services (36.7%): support services, training, etc. Net sales are distributed by market between pharmaceutical (58.6%), industrial (29.9%), academic institutions and governmental agencies (11.4%). Net sales are distributed geographically as follows: the United States (28.7%), Americas (5.1%), China (17.1%), Japan (7.6%), Asia (13.3%) and Europe (28.2%).

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-07 - Q1 2024 Earnings Release

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Waters Corporation

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

299.2 USD

Average target price

325.1 USD

Spread / Average Target

+8.65%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
WATERS CORPORATION	-4.34%	17.75B
THERMO FISHER SCIENTIFIC	+8.32%	209B
DANAHER CORPORATION	+9.62%	175B
INTUITIVE SURGICAL, INC.	+12.42%	131B
BOSTON SCIENTIFIC CORPORATION	+19.07%	99.98B
SIEMENS HEALTHINEERS AG	-0.84%	61.12B
EDWARDS LIFESCIENCES CORPORATION	+15.19%	52.34B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-2.10%	46.5B
AGILENT TECHNOLOGIES, INC.	+0.11%	39.24B
GE HEALTHCARE TECHNOLOGIES INC.	+11.83%	38.47B

Other Advanced Medical Equipment & Technology